收藏切换
Pharmacological research and application of aromatic orifice-opening drugs in prevention and treatment of Alzheimer’s disease
收藏切换
PDF
Chinese Traditional and Herbal Drugs | 2026, 57(15) : 6172 - 6182
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2026, 57(15): 6172-6182
Pharmacological research and application of aromatic orifice-opening drugs in prevention and treatment of Alzheimer’s disease
Full
HE Haili, LI Yuan, WANG Hongyan, ZHANG Can, YUAN Xianjiang, YANG Hongwei, CHEN Shaoxu, QIAN Haibing
Affiliations
doi: 10.7501/j.issn.0253-2670.2026.15.032
Outline
收藏切换
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline. Its pathological mechanisms are complex, involving multiple key links such as beta-amyloid protein (Aβ) deposition, excessive phosphorylation of Tau protein, neuroinflammation and synaptic dysfunction. Traditional Chinese medicine (TCM) categorizes AD under conditions like “dementia” and “forgetfulness”, with the core pathogenesis being “deficiency at the root and excess at the surface”, where kidney essence deficiency is the root cause and phlegm turbidity and blood stasis obscuring the orifices are the surface manifestations. As a distinctive TCM therapy, aromatic orifice-opening drugs, with their pungent, fragrant and penetrating nature that can reach and regulate meridians, follow the principle of “awakening the orifices and refreshing the mind, resolving phlegm and dispelling foulness”, demonstrating unique advantages in the prevention and treatment of AD. Representative drugs include Shichɑngpu (Acori Tatarinowii Rhizoma), Yuanzhi (Polygalae Radix), Shexiang (Moschus), Bingpiɑn (Borneolum Syntheticum), etc. Modern pharmacological research has revealed their multi-target intervention potential, including inhibiting Aβ generation and aggregation, reducing Tau protein phosphorylation, anti-neuroinflammation, anti-oxidative stress, and regulating neurotransmitters and promoting neurogenesis. Commonly used TCM formulas with the effect of aromatic orifice-opening such as Angong Niuhuang Pill (安宫牛黄丸), Suhexiang Pill (苏合香丸) and Changpu Yujin Decoction (菖蒲郁金汤) have shown good efficacy in improving patients’ cognitive function, memory, and daily living abilities through compatibility and synergy. This review systematically summarizes the research and application status of aromatic orifice-opening drugs in the prevention and treatment of AD, providing theoretical basis and practical references for the intervention of AD by aromatic orifice-opening TCMs.
Alzheimer’s disease  /  aromatic orifice-opening drugs  /  compatibility of traditional Chinese medicine  /  Acori Tatarinowii Rhizoma  /  Polygalae Radix  /  Moschus  /  Borneolum Syntheticum
HE Haili, LI Yuan, WANG Hongyan, ZHANG Can, YUAN Xianjiang, YANG Hongwei, CHEN Shaoxu, QIAN Haibing. Pharmacological research and application of aromatic orifice-opening drugs in prevention and treatment of Alzheimer’s disease[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (15) : 6172 -6182 . DOI: 10.7501/j.issn.0253-2670.2026.15.032
Year 2026 volume 57 Issue 15
PDF
31
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2026.15.032
  • Receive Date:2026-02-19
  • Online Date:2026-09-09
Article Data
Affiliations
History
  • Received:2026-02-19
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2026.15.032
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT